| H Norman Xu M D Inc | |
|
7111 Winnetka Ave Suite 4 Canoga Park CA 91306-3646 | |
| (818) 888-3123 | |
| (818) 888-3331 |
| Full Name | H Norman Xu M D Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 7111 Winnetka Ave, Canoga Park, California |
| Authorized Official Name and Position | Haixin Norman Xu (PRESIDENT) |
| Authorized Official Contact | 8188883123 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| H Norman Xu M D Inc 7111 Winnetka Ave Suite 4 Canoga Park CA 91306-3646 Ph: (818) 888-3123 | H Norman Xu M D Inc 7111 Winnetka Ave Suite 4 Canoga Park CA 91306-3646 Ph: (818) 888-3123 |
| NPI Number | 1134307259 |
|---|---|
| Provider Enumeration Date | 01/31/2008 |
| Last Update Date | 09/14/2010 |
| Medicare PECOS PAC ID | 1658271648 |
|---|---|
| Medicare Enrollment ID | O20040113000777 |
News Archive
A new study, released as a preprint on bioRxiv* server, shows that a combination of the biological interferon-α and the small molecule nafamostat are effective against SARS-CoV-2 infection in vitro, as well as in vivo.
Celgene International Sàrl today announced that data from a pivotal Phase II, multicenter, international, open-label study of romidepsin (ISTODAX) in progressive or relapsed PTCL following prior systemic therapy were presented at the 52nd American Society of Hematology Annual Meeting.
Cancer Research UK scientists have discovered the first DNA faults linked to melanoma - the deadliest skin cancer - that are not related to hair, skin or eye colour, according to research published in Nature Genetics today.
Catalyst Pharmaceutical Partners, Inc. today announced that the Company will continue to develop CPP-109 (Catalyst's version of vigabatrin) for the treatment of cocaine and methamphetamine addiction.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134307259 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A66736 (California) | Primary |
| Provider Name | Haixin Norman Xu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1124019138 PECOS PAC ID: 1557261542 Enrollment ID: I20040116000361 |
News Archive
A new study, released as a preprint on bioRxiv* server, shows that a combination of the biological interferon-α and the small molecule nafamostat are effective against SARS-CoV-2 infection in vitro, as well as in vivo.
Celgene International Sàrl today announced that data from a pivotal Phase II, multicenter, international, open-label study of romidepsin (ISTODAX) in progressive or relapsed PTCL following prior systemic therapy were presented at the 52nd American Society of Hematology Annual Meeting.
Cancer Research UK scientists have discovered the first DNA faults linked to melanoma - the deadliest skin cancer - that are not related to hair, skin or eye colour, according to research published in Nature Genetics today.
Catalyst Pharmaceutical Partners, Inc. today announced that the Company will continue to develop CPP-109 (Catalyst's version of vigabatrin) for the treatment of cocaine and methamphetamine addiction.
› Verified 3 days ago
News Archive
A new study, released as a preprint on bioRxiv* server, shows that a combination of the biological interferon-α and the small molecule nafamostat are effective against SARS-CoV-2 infection in vitro, as well as in vivo.
Celgene International Sàrl today announced that data from a pivotal Phase II, multicenter, international, open-label study of romidepsin (ISTODAX) in progressive or relapsed PTCL following prior systemic therapy were presented at the 52nd American Society of Hematology Annual Meeting.
Cancer Research UK scientists have discovered the first DNA faults linked to melanoma - the deadliest skin cancer - that are not related to hair, skin or eye colour, according to research published in Nature Genetics today.
Catalyst Pharmaceutical Partners, Inc. today announced that the Company will continue to develop CPP-109 (Catalyst's version of vigabatrin) for the treatment of cocaine and methamphetamine addiction.
› Verified 3 days ago
My Gastro Wellness. Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 22110 Roscoe Blvd, Suite 201, Canoga Park, CA 91304 Phone: 747-204-4177 Fax: 818-431-8283 | |
None Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 21041 Parthenia St Unit 158, Canoga Park, CA 91304 Phone: 818-267-8479 Fax: 818-450-0272 | |
Smartcare Community Clinic Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7018 Owensmouth Ave, Canoga Park, CA 91303 Phone: 747-388-2080 | |
Sol Weiss, M.d.,inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 22030 Sherman Way, Suite 118, Canoga Park, CA 91303 Phone: 818-346-1515 Fax: 818-346-1524 | |
Highland Do Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7251 Owensmouth Ave, Suite 6, Canoga Park, CA 91303 Phone: 818-883-4100 Fax: 818-883-4105 | |
Bendito Pediatrics Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 22030 Sherman Way, Suite #210, Canoga Park, CA 91303 Phone: 818-857-5991 Fax: 818-703-0895 |